Larvol Delta - ACELYRIN-INC-Announces-Positive-Topline-Results-from-Its-Global-Phase-2b3-Clinical-Trial-of-Izokibep-in-Psoriatic-Arthritis

izokibep (ABY-035) - ACELYRIN

https://www.globenewswire.com/news-release/2024/03/11/2843753/0/en/ACELYRIN-INC-Announces-Positive-Top-line-Results-from-Its-Global-Phase-2b-3-Clinical-Trial-of-Izokibep-in-Psoriatic-Arthritis.html

Mar 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next